Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head and Neck Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06982105
What this trial is testing

Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

Who this might be right for
Methicillin Resistant Staphylococcus AureusOsteomyelitis AcuteSeptic Arthritis+6 more
Indiana University 100
Not applicableStudy completedNCT00897273
What this trial is testing

Oral HPV Infection in Young Men

Who this might be right for
Head and Neck CancerInfectionPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 500
Not applicableEnded earlyNCT01257100
What this trial is testing

Environmental and Genetic Determinants of NPC

Who this might be right for
Nasopharyngeal NeoplasmsHerpesvirus 4, Human
National Cancer Institute (NCI) 3,500
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Not applicableUnknownNCT04163029
What this trial is testing

Oral Care Study of Postoperative Infections

Who this might be right for
Cancer, Mouth
University of Liege 50
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Testing effectiveness (Phase 2)Study completedNCT00834093
What this trial is testing

A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Dana-Farber Cancer Institute 18
Not applicableEnded earlyNCT03321903
What this trial is testing

EPR Tumor Oximetry With CE India Ink

Who this might be right for
Neoplasms, MalignantBreast NeoplasmCarcinoma, Basal Cell+4 more
Philip Schaner 3
Testing effectiveness (Phase 2)Ended earlyNCT02706691
What this trial is testing

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Who this might be right for
FGFR Gene AmplificationFGFR1 Gene AmplificationFGFR2 Gene Amplification+7 more
University of Chicago 1
Testing effectiveness (Phase 2)Ended earlyNCT04916002
What this trial is testing

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+3 more
Regeneron Pharmaceuticals 77
Testing effectiveness (Phase 2)Ended earlyNCT02874651
What this trial is testing

ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 25
Not applicableLooking for participantsNCT06787456
What this trial is testing

"Xijiang Project" Screening Cohort for NPC

Who this might be right for
Nasopharyngeal Carcinoma (NPC)Screening
Ming-Yuan Chen 1,000,000
Not applicableLooking for participantsNCT06682442
What this trial is testing

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaStage III Nasopharyngeal Carcinoma AJCC v8Stage IVA Nasopharyngeal Carcinoma AJCC v8+2 more
University of California, San Francisco 66
Not applicableUnknownNCT04425122
What this trial is testing

The Microbiome of Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerMicrobial Colonization
Chinese University of Hong Kong 200
Testing effectiveness (Phase 2)Ended earlyNCT04015336
What this trial is testing

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

Who this might be right for
Papillomavirus InfectionsOropharyngeal Neoplasms
National Cancer Institute (NCI) 1
Not applicableLooking for participantsNCT07033091
What this trial is testing

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Who this might be right for
Oropharynx Cancer
The Institute of Molecular and Translational Medicine, Czech Republic 20,000
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Next Page